Characterizing the HIV/AIDS Epidemic in the Middle East and North Africa : Time for Strategic Action

Vista sencilla de ítem
dc.creatorAbu-Raddad, Laith J.
dc.creatorAkala, Francisca Ayodeji
dc.creatorSemini, Iris
dc.creatorRiedner, Gabriele
dc.creatorWilson, David
dc.creatorTawil, Ousama
dc.date2012-03-19T09:34:05Z
dc.date2012-03-19T09:34:05Z
dc.date2010
dc.date.accessioned2026-07-01T00:47:02Z
dc.descriptionDespite a fair amount of progress on understanding human immunodeficiency virus (HIV) epidemiology globally, the Middle East and North Africa (MENA) region is the only region where knowledge of the epidemic continues to be very limited, and subject to much controversy. It has been more than 25 years since the discovery of HIV, but no scientific study has provided a comprehensive data-driven synthesis of HIV/AIDS (acquired immunodeficiency syndrome) infectious spread in this region. The current report provides the first comprehensive scientific assessment and data-driven epidemiological synthesis of HIV spread in MENA since the beginning of the epidemic. It is based on a literature review and analysis of thousands of widely unrecognized publications, reports, and data sources extracted from scientific literature or collected from sources at the local, national, and regional levels. The recommendations provided here focus on key strategies related to the scope of this report and its emphasis on understanding HIV epidemiology in MENA as a whole. The recommendations are based on identifying the status of the HIV epidemic in MENA, through this synthesis, as a low HIV prevalence setting with rising concentrated epidemics among priority populations. General directions for prevention interventions as warranted by the outcome of this synthesis are also discussed briefly, but are not delineated because they are beyond the scope of this report. This report was not intended to provide intervention recommendations for each MENA country.
dc.formatapplication/pdf
dc.formattext/plain
dc.identifierhttp://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000333038_20100604011533
dc.identifier978-0-8213-8137-3
dc.identifierhttps://hdl.handle.net/10986/2457
dc.identifier10.1596/978-0-8213-8137-3
dc.identifier.urihttp://hdl.handle.net/123456789/410929
dc.languageEnglish
dc.publisherWorld Bank
dc.rightsCC BY 3.0 IGO
dc.rightshttp://creativecommons.org/licenses/by/3.0/igo
dc.rightsWorld Bank
dc.subjectACCESS TO CONDOMS
dc.subjectACCESS TO INTERVENTIONS
dc.subjectACQUIRED IMMUNODEFICIENCY SYNDROME
dc.subjectADVOCACY EFFORTS
dc.subjectAIDS CASES
dc.subjectAT-RISK GROUPS
dc.subjectAWARENESS RAISING
dc.subjectBEHAVIORAL SURVEILLANCE
dc.subjectBILATERAL DONORS
dc.subjectBLOOD DONORS
dc.subjectBREASTFEEDING
dc.subjectCHILDBIRTH
dc.subjectCOMMERCIAL SEX
dc.subjectCOMMERCIAL SEX WORK
dc.subjectCOMMERCIAL SEX WORKER
dc.subjectCONDOM
dc.subjectCONDOM USE
dc.subjectCRIME
dc.subjectDISEASES
dc.subjectDRUG USER
dc.subjectDRUGS
dc.subjectECONOMIC CONDITIONS
dc.subjectEFFECTIVE PREVENTION
dc.subjectEPIDEMICS
dc.subjectEPIDEMIOLOGICAL SURVEILLANCE
dc.subjectFAMILIES
dc.subjectFAMILY HEALTH
dc.subjectFAMILY MEMBERS
dc.subjectHARM REDUCTION
dc.subjectHEALTH
dc.subjectHEALTH EXPENDITURES
dc.subjectHEALTH FACILITIES
dc.subjectHEALTH SERVICES
dc.subjectHEPATITIS C
dc.subjectHIGH RISK OF INFECTION
dc.subjectHIGH-RISK
dc.subjectHIGH-RISK GROUPS
dc.subjectHIGH-RISK POPULATIONS
dc.subjectHIV
dc.subjectHIV INFECTION
dc.subjectHIV INFECTIONS
dc.subjectHIV PREVENTION
dc.subjectHIV TESTING
dc.subjectHUMAN IMMUNODEFICIENCY VIRUS
dc.subjectIMMUNODEFICIENCY
dc.subjectINJECTING DRUG USE
dc.subjectINJECTING DRUG USERS
dc.subjectINSTITUTIONAL DEVELOPMENT
dc.subjectINTERVENTION
dc.subjectINTIMATE RELATIONSHIPS
dc.subjectLIFE EXPECTANCY
dc.subjectLIFESTYLES
dc.subjectLOW PREVALENCE
dc.subjectMALARIA
dc.subjectMEDICAL CARE
dc.subjectMEDICAL RESEARCH
dc.subjectMIGRANTS
dc.subjectMIGRATION
dc.subjectMOTHER-TO-CHILD
dc.subjectMOTHER-TO-CHILD TRANSMISSION
dc.subjectMULTIPLE SEX PARTNERS
dc.subjectNEW INFECTIONS
dc.subjectNUMBER OF AIDS DEATHS
dc.subjectNUTRITION
dc.subjectPANDEMIC
dc.subjectPARENTHOOD FEDERATION
dc.subjectPATIENTS
dc.subjectPREVALENCE RATE
dc.subjectPREVALENCE RATES
dc.subjectPREVENTION EFFORTS
dc.subjectPREVENTION INTERVENTIONS
dc.subjectPRISONS
dc.subjectPRIVATE PROVIDERS
dc.subjectPRODUCTIVITY
dc.subjectPUBLIC HEALTH
dc.subjectREDUCTION IN TRANSMISSION
dc.subjectREFUGEES
dc.subjectRELIGIOUS LEADERS
dc.subjectRISK BEHAVIORS
dc.subjectRISK FACTORS
dc.subjectRISK OF INFECTION
dc.subjectRISK POPULATIONS
dc.subjectRISK TAKING
dc.subjectSAFE NEEDLES
dc.subjectSAVINGS
dc.subjectSCHOOLS
dc.subjectSCREENING
dc.subjectSEX WITH MEN
dc.subjectSEX WORKER
dc.subjectSEXUAL ACTIVITIES
dc.subjectSEXUAL EDUCATION
dc.subjectSEXUALLY TRANSMITTED INFECTIONS
dc.subjectSOCIAL DEVELOPMENT
dc.subjectSTIS
dc.subjectSUBSIDIARY
dc.subjectSURVEILLANCE ACTIVITIES
dc.subjectSURVEILLANCE DATA
dc.subjectTECHNICAL ASSISTANCE
dc.subjectTUBERCULOSIS
dc.subjectUNAIDS
dc.subjectUNEMPLOYMENT
dc.subjectVERTICAL TRANSMISSION
dc.subjectVIOLENCE
dc.subjectVOLUNTARY COUNSELING
dc.subjectVULNERABLE GROUPS
dc.subjectWORLD HEALTH ORGANIZATION
dc.subjectYOUNG ADULTS
dc.subjectYOUTH
dc.titleCharacterizing the HIV/AIDS Epidemic in the Middle East and North Africa : Time for Strategic Action

Archivos

Colecciones

AgroKnow